Interestingly, Fingolimod was also demonstrated in vitro to promote anti-cancer effect of EGFR targeting, Cisplatin, or Permetrexed treatments in NSCLC models [34,35,36]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.